Literature DB >> 7579391

The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor.

G de Haan1, B Dontje, C Engel, M Loeffler, W Nijhof.   

Abstract

Because of the complexity of appropriate stem cell assays, little information on the in vivo regulation of murine stem cell biology or stemmatopoiesis is available. It is unknown whether and how in vivo the primitive hematopoietic stem cell compartment is affected during a continued increased production of mature blood cells. In this study, we present data showing that prolonged (3 weeks) administration of granulocyte colony-stimulating factor (G-CSF), which is a major regulator of mature granulocyte production, has a substantial impact on both the size and the location of various stem cell subset pools in mice. We have used the novel cobblestone area forming cell (CAFC) assay to assess the effects of G-CSF on the stem cell compartment (CAFC days 7, 14, 21, and 28). In marrow, in which normally 99% of the total number of stem cells can be found, G-CSF induced a severe depletion of particularly the most primitive stem cells to 5% to 10% of normal values. The response after 7 days of G-CSF treatment was an increased amplification between CAFC day 14 and 7. However, this response occurred at the expense of the number of CAFC day 14. It is likely that the resulting gap of CAFC day 14 cell numbers was subsequently replenished from the more primitive CAFC day 21 and 28 compartments, because these cell numbers remained low during the entire treatment period. In the spleen, the number of stem cells increased, likely caused by a migration from the marrow via the blood, leading to an accumulation in the spleen. The increased number of stem cells in the spleen overcompensated for the loss in the marrow. When total body (marrow and spleen) stem cell numbers were calculated, it appeared that a continued increased production of mature granulocytes resulted in the establishment of a higher, new steady state of the stem cell compartment; most committed stem cells (CAFC day 7) were increased threefold, CAFC day 14 were increased 2.3-fold, CAFC-day 21 were increased 1.8-fold, and the most primitive stem cells evaluated, CAFC day 28, were not different from normal, although now 95% of these cells were located in the spleen. Four weeks after discontinuation of the G-CSF treatment, the stem cell reserve in the spleen had returned to a normal level, whereas stem cell numbers in marrow had recovered to values above normal. This study shows that the primitive stem cell compartment is seriously perturbed during an increased stimulation of the production of mature blood cells.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579391

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization.

Authors:  S J Morrison; D E Wright; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

2.  Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice.

Authors:  Jeffrey M Bernitz; Michael G Daniel; Yesai S Fstkchyan; Kateri Moore
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

3.  G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells.

Authors:  Hyun Kyung Kim; Maria De La Luz Sierra; Cassin Kimmel Williams; A Virginia Gulino; Giovanna Tosato
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

4.  Regulation of hematopoietic stem cell activity by inflammation.

Authors:  Laura G Schuettpelz; Daniel C Link
Journal:  Front Immunol       Date:  2013-07-19       Impact factor: 7.561

5.  M-CSF improves protection against bacterial and fungal infections after hematopoietic stem/progenitor cell transplantation.

Authors:  Prashanth K Kandalla; Sandrine Sarrazin; Kaaweh Molawi; Carole Berruyer; David Redelberger; Anne Favel; Christophe Bordi; Sophie de Bentzmann; Michael H Sieweke
Journal:  J Exp Med       Date:  2016-10-10       Impact factor: 14.307

6.  Stem cell fate analysis revisited: interpretation of individual clone dynamics in the light of a new paradigm of stem cell organization.

Authors:  Ingo Roeder; Katrin Braesel; Ronny Lorenz; Markus Loeffler
Journal:  J Biomed Biotechnol       Date:  2007-04-18

7.  G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses.

Authors:  Mark P Rubinstein; Mohamed L Salem; Andrew L Doedens; Caitlin J Moore; Cody Chiuzan; Guillermo L Rivell; David J Cole; Ananda W Goldrath
Journal:  J Hematol Oncol       Date:  2013-10-01       Impact factor: 17.388

8.  G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling.

Authors:  L G Schuettpelz; J N Borgerding; M J Christopher; P K Gopalan; M P Romine; A C Herman; J R Woloszynek; A M Greenbaum; D C Link
Journal:  Leukemia       Date:  2014-02-12       Impact factor: 11.528

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.